Christine Årdal
-
- Antibiotic Use and Resistance 24
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 7
- Microbiology top 10%
- Economics and Econometrics top 5%
- Pharmaceutical Economics and Policy 25
- Health Systems, Economic Evaluations, Quality of Life 5
-
- Biosimilars and Bioanalytical Methods 7
-
- Biotechnology and Related Fields 4
- Pharmaceutical Quality and Counterfeiting 4
-
- Pharmaceutical industry and healthcare 3
- Co-authors
- Kevin OuttersonJohn‐Arne RøttingenJohn RexRamanan LaxminarayanManica BalasegaramNithima SumpraditDavid McAdamsStephen A. Matlin
- Journals
- The Lancet (1 paper)Nature Communications (2 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Christine Årdal
41 papers receiving 949 citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Applied Microbiology and Biotechnology 251
- Molecular Medicine 192
- Microbiology 60
- Economics and Econometrics 246
- Business and International Management 13
Countries citing papers authored by Christine Årdal
This map shows the geographic impact of Christine Årdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Årdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Årdal more than expected).
Fields of papers citing papers by Christine Årdal
This network shows the impact of papers produced by Christine Årdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Årdal. The network helps show where Christine Årdal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christine Årdal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 10 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 14 | |
| 12 | 2018 | 10 | |
| 13 | Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access | 2018 | 33 |
| 14 | 2018 | 14 | |
| 15 | 2018 | 49 | |
| 16 | 2018 | 20 | |
| 17 | 2018 | 25 | |
| 18 | 2017 | 10 | |
| 19 | 2016 | 2 | |
| 20 | 2013 | 197 |
About Christine Årdal
Christine Årdal is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Business and International Management, having authored 46 papers that have together received 988 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (25 papers), Antibiotic Use and Resistance (24 papers), Antibiotic Resistance in Bacteria (7 papers), Biosimilars and Bioanalytical Methods (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Biotechnology and Related Fields (4 papers), Pharmaceutical Quality and Counterfeiting (4 papers) and Pharmaceutical industry and healthcare (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (251 citations), Molecular Medicine (192 citations) and Microbiology (60 citations). Christine Årdal has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Kevin Outterson, John‐Arne Røttingen, John Rex, Ramanan Laxminarayan, Manica Balasegaram, Nithima Sumpradit, David McAdams, Stephen A. Matlin, Roderik F. Viergever and Robert Terry. Their work appears in journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.